FDA’s Peter Marks Resigns Amid Conflict Over Vaccine Policy and Leadership Changes at HHS
Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER), submitted his resignation on Friday, effective immediately. His departure follows a request to step down from officials within the Trump administration, according to individuals familiar with the matter. Dr. Marks oversaw vaccine approvals, gene therapies, …
“Dr. Drew Pinsky: ‘The Secret to Longevity'” (Sponsored)
Dr. Drew, Chief Patient Officer at The Wellness Company, has a clear favorite when it comes to supplements: Nicotinamide Riboside (NR). He’s said, “If I had access to only one supplement, NR would be that supplement. The fact that it’s not more widely used and distributed I just can’t get …
“The Prison of Certainty: Why We Resist Reconsidering Our Beliefs”
In yesterday’s essay on ‘Parallel Realities,’ I explored how algorithmic sorting and information manipulation have created fragmented realities where we no longer share a common understanding of facts. Today, I’ll dig into the flip side: why our minds cling to beliefs despite evidence of manipulation. A saying, dubiously tied to …
“CoreWeave’s IPO Miss Raises Questions About AI Market and Broader Economic Sentiment”
CoreWeave, a provider of cloud-based computing power for the artificial intelligence sector, completed its long-anticipated initial public offering this week—marking the largest I.P.O. of the year thus far. However, the results fell significantly short of expectations, raising concerns not just about the company’s individual performance, but about investor sentiment toward …
“Censorship in the EU: Hate Speech Laws Are Suffocating Free Speech”
Police raids on people’s homes for posting a meme, criminal charges for hate speech and posting misinformation – no longer a dystopian film or a glimpse from China or Russia, but reality in several EU countries. Especially in Germany, the EU’s largest country, where the authorities have taken a particularly …





